DRKS00032452
Recruiting
未知
Investigating the effectiveness of the digital lifestyle intervention actensio to reduce blood pressure in adults with hypertension after six months of use - ACTENSIO
mementor DE GmbH0 sites422 target enrollmentJanuary 24, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- I10
- Sponsor
- mementor DE GmbH
- Enrollment
- 422
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Consent to participate in the clinical trial
- •\- Age over 18 years
- •\- Diagnosis of essential hypertension (practice SBP 140\-179 mmHg and/or DBP 90\-109 mmHg; 24\-h SBP\=130\- mmHg and/or 24\-h DBP\=80\)
- •\- Internet access and computer/smartphone compatible with actensio
- •\- Able to complete data collection and intervention
- •\- Ability to speak and read German
- •\- Antihypertensive medication (prescribed by a doctor) that has been stable over the last 3 months (i.e. not changed) or no antihypertensive medication
- •\- Possession of a blood pressure monitor
- •\- Patients are able to participate fully in the clinical trial and comply with the requirements for participation
Exclusion Criteria
- •\- Taking \= 4 different classes of blood pressure medication
- •\- Practice SBP \= 180 and/or DBP \= 110
- •\- Life expectancy \< 12 months
- •\- Cardiovascular event within the last 6 months (e.g. stroke, heart attack, cerebral haemorrhage)
- •\- Cancer diagnosis in the past 5 years or acute treatment with chemotherapy/immonosuppressants
- •\- Current or planned pregnancy during the clinical trial; breastfeeding women
- •\- cognitive impairment
- •\- Participation in another clinical drug trial or medical device trial
- •\- current or recent (within the last six months) participation in a lifestyle intervention programme (e.g. sports or diet programme)
- •\- Employees of mementor or another institution involved in the conduct/organisation/coordination/financing of the clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation of the effectiveness of the digital intervention glykio for improving lifestyle and self-management in patients with type 2 diabetes mellitus (T2DM) after three months' useE11Type 2 diabetes mellitusDRKS00032134mementor DE GmbH76
Completed
Not Applicable
Effectiveness of Digital therapeutics in clinical symptoms of Attention Deficit/Hyperactivity DisorderMental and behavioural disordersKCT0007579CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITA40
Not yet recruiting
Phase 3
Evaluation of the effectiveness of a digital aftercare intervention for depression. A prospective randomized controlled trialF32.1F32.2F33.1F33.2F32.0F33.0Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsMild depressive episodeRecurrent depressive disorder, current episode mildDRKS00016663Friedrich-Alexander-University Erlangen-Nuremberg Department of Clinical Psychology and Psychotherapy102
Recruiting
Not Applicable
Evaluation of the scope and efficacy of a digitised, innovative psychosocial recovery program for individuals post- Motor Vehicle Accident (MVA)Soft-Tissue Injuries (STI)Orthopaedic InjuriesInjuries and Accidents - Other injuries and accidentsACTRN12623000551695The University of Sydney100
Active, not recruiting
Not Applicable
Evaluation of a co-developed digital self-management program to reduce sedentary time and increase adherence to reduced sedentary time in older adults in transition to retirementHealth promotion in older adults in transition to retirement.Not ApplicableISRCTN13045377Mälardalen University43